Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women (original) (raw)

Profile image of Suzanne GarlandSuzanne GarlandProfile image of Cosette WheelerCosette Wheeler

2010, JNCI Journal of the National Cancer Institute

visibility

description

15 pages

link

1 file

The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed population of HPV-exposed and -unexposed women (intention-to-treat group).